Although soy foods have been recognized as an excellent source of protein, there have been recent concerns regarding potential adverse effects of isoflavone phytochemicals found in soy products, which are known to bind and activate estrogen receptors. Here, we used global hepatic gene expression profiles in ovariectomized female SpragueDawley rats treated with 17b-estradiol (E 2 ) or fed with soy protein isolate (SPI) as a means of estimating potential estrogenicity of SPI. Female Sprague-Dawley rats were fed AIN-93G diets containing casein (CAS) or SPI starting at postnatal day (PND) 30. Rats were ovariectomized on PND 50 and infused with E 2 or vehicle in osmotic pumps for 14 d. Microarray analysis was performed on liver using Affymetrix GeneChip Rat 230 2.0. Serum E 2 levels were within normal ranges for the rat and SPI feeding did not increase uterine wet weight in the absence or presence of E 2 . SPI feeding altered (P!0 . 05, RG1 . 5-fold) the expression of 82 genes, while E 2 treatment altered 892 genes. Moreover, only 4% of E 2 -affected genes were also modulated by SPI, including some whose expression was reversed by SPI feeding. The interaction between E 2 and SPI uniquely modulated the expression profile of 225 genes including the reduction of those involved in fatty acid biosynthesis or glucocorticoid signaling and an induction of those involved in cholesterol metabolism. The different hepatic gene signatures produced by SPI feeding compared with E 2 and the lack of increase in uterine wet weight in rats fed with SPI suggest that SPI is not estrogenic in these tissues.
Introduction
Soy is a popular dietary constituent in Asian countries such as Japan, Korea, and China. Lately, there has been an increasing use of soy products in western diets as the result of purported health benefits. There is epidemiological evidence suggesting that soy consumption reduces the risk of hormonal cancers, such as breast, ovarian, and prostate cancers, in addition to chronic diseases such as obesity, atherosclerosis, diabetes, and renal disease (Clair & Anthony 2005 , Goetzl et al. 2007 , Velasquez & Bhathena 2007 . Mechanistic laboratory studies suggest that soy-associated phytochemicals (O137; Fang et al. 2004) , and soy protein, independently or synergistically, may be responsible for the plethora of beneficial effects associated with soy consumption. Some of the phytochemicals associated with soy such as isoflavones, saponins, and phytosterols have endocrine actions (Munro et al. 2003) . The isoflavones -genistein and daidzein, as well as the daidzein metabolite equol -have molecular structures similar to endogenous estrogens and bind to estrogen receptors (ER) a and b (Setchell 2001) . They have been shown to be estrogenic, anti-estrogenic, or partial agonists depending upon the tissue, cell type, isoflavone concentration, and other conditions, such as age and hormonal status (Barkhem et al. 1998 , Patisaul et al. 2001 , Hwang et al. 2006 . Due to this property, they are often referred to as 'selective ER modulators (SERMs)' (Setchell 2001) . There has been considerable interest in the estrogenic activity of diets that contain soy isoflavones with regard to potential for alleviation of post-menopausal symptoms. However, the same property has raised legitimate concerns regarding estrogenization in infants fed soy formula, males, and pre-pubertal females (Munro et al. 2003 , McLachlan et al. 2006 .
Isoflavones occur in soy protein isolate (SPI) and other soy products as polar b-glycoside conjugates, such as genistin and daidzin. Bacterial hydrolysis of these isoflavones, in the GI tract, releases the principal bioactive aglycones, genistein, and daidzein. These aglycones and bacterial metabolites such as the daidzein metabolite equol are absorbed from the intestinal tract and conjugated in both the intestinal mucosa and the liver mainly to glucuronides and sulfates ; only 1-5% of the aglycones remain unconjugated. Fermented soy products such as miso and tempeh, may contain a higher concentration of aglycones (Barrett 2006 , Rozman et al. 2006 . The route and concentration of exposure to isoflavones, the animal model, soy processing, gut microflora, and endogenous estrogenic status are among many factors that play crucial roles in determining health outcomes of soy consumption. Soy foods have a long history in Asia of being safe, and evidence continues to mount regarding the health benefits of soy consumption. By contrast, data generated from purified isoflavones, used at pharmaceutical concentrations and/or injected into rodents, suggest a risk of reproductive dysfunctions including endometrial and uterine hyperplasia in females and reduced sperm count in males (Delclos et al. 2001 , Nagao et al. 2001 , Unfer et al. 2004 .
Previous observations from our laboratory suggested reduced carcinogenicity and atherosclerosis in animals fed soy diets (Badger et al. 2005 , Singhal et al. 2008a . Moreover, we have reported no compromise of cognitive function in infants fed soy formula ( Jing et al. 2008) . Nonetheless, the safety concerns regarding potential estrogenicity of soy foods cannot be ignored. The present study examines the questionis SPI estrogenic in the liver? The objective was to compare the effect of SPI diets with actions of the endogenous estrogen, 17b-estradiol (E 2 ). Mature ovariectomized female SpragueDawley rats were fed with a diet containing SPI and followed by E 2 infusion in half of the rats. The effects of feeding SPI in the presence or absence of E 2 were compared with E 2 using uterine wet weight and hepatic gene expression profile.
Materials and Methods

Animal care and experiment design
The experiment received prior approval from the Institutional Animal Care and Use Committee at UAMS. Adult female Sprague-Dawley rats were purchased from Charles River Laboratories and were fed diets made with casein (CAS) or SPI. Semi-purified diets were made according to the AIN-93G formula (Reeves et al. 1993) except that corn oil replaced soybean oil and the protein source was either CAS or SPI (Singhal et al. 2007 ). The SPI diet had 430 mg total isoflavones/kg containing 276 mg/kg genistein and 132 mg/kg daidzein. Average daily consumption of genistein and daidzein were 19 . 3 mg/kg per day and 9 . 2 mg/kg per day respectively. Total isoflavone concentrations in 24-h urine pools was w40 mmol/l .
Rats were fed SPI or CAS diets (NZ12 in each group) from postnatal day (PND) 30 until PND 64. On PND 50, rats were ovariectomized. Half of each group was subcutaneously infused with E 2 and half with polyethylene glycol vehicle (Sigma) using Alzet 2002 mini-osmotic pumps (Alza Corp., Mountain View, CA, USA) that were calibrated to release 0 . 5 ml/h for 14 d to produce an E 2 dose of 5 mg/kg per day.
On PND 64, all the rats were anesthetized with Nembutal (100 mg/kg, i.p.) followed by decapitation. Blood, liver, and uterus were collected and frozen at K80 8C until analysis. Treatment groups were designated as: 1) Control, CAS diet; 2) E 2 , E 2 treatment on CAS background; 3) SPI, SPI diet; and 4) SPICE 2 , E 2 treatment on SPI background.
Isoflavone and E 2 analyses
Serum isoflavones (total serum isoflavones) were measured by LC-MS or electrochemical detection after conjugate hydrolysis, as described in detail by Gu et al. (2006) . Serum E 2 levels were determined by ultra-sensitive RIA, using DSL-4800 kit (Diagnostic Systems Laboratories, Webster, TX, USA) following the manufacturer's protocol. The kit has a lower detection limit of 2 . 2 pg/ml of E 2 .
Microarray preparation, normalization, and data analysis
Microarray preparation and data analysis were performed following minimum information about microarray experiments -supportive relational database (Brazma et al. 2001) . Total RNA was isolated and cleaned using w100 mg hepatic tissue using TRI reagent (Molecular Research Center Inc, Cincinnati, OH, USA) from three rats in each treatment group, as described previously (Singhal et al. 2008b) . First-and second-strand cDNA synthesis, biotin-labeled cRNA synthesis, fragmentation of cRNA, and hybridization reactions were performed using one-cycle cDNA synthesis kit (Affymetrix Inc, Santa Clara, CA, USA). Briefly, 8 mg purified RNA was used to synthesize cDNA. Labeled cRNA was synthesized from cDNA using a GeneChip IVT labeling kit (Affymetrix) according to the manufacturer's instructions. Twenty micrograms cRNA was then fragmented in a solution of 5! fragmentation buffer and RNase for 35 min. Complementary RNAs from each rat liver (nZ3) were hybridized to an individual Affymetrix GeneChip Rat genome 230 2.0. for 16 h at 45 8C in the hybridization oven set at 60 r.p.m. The probe array was washed and stained using Affymetrix kit in GeneChip fluidics station 450 and scanned using GeneChip Scanner 3000. For each of the 31 099 genes on the Affymetrix Rat genome 230 2.0 array, the data on induction or repression values were analyzed using GeneChip Operating Software obtained from Affymetrix.
The data files (.CEL files) containing the probe-level intensities were processed using the robust multiarray analysis algorithm (GeneSpring 7.3!, Agilent Technologies Inc., Wilmington, MA, USA) for background correction, normalization, and log2 transformation (Irizarry et al. 2003) . Subsequently, the data were subjected to per-chip and pergene normalization using GeneSpring normalization algorithms. A list of differentially expressed genes was generated by performing one-way ANOVA (P!0 . 05; Welch) analysis followed by Benjamini and Hochberg false discovery rate and Student-Newman-Keuls multiple testing correction. This list was used to make comparisons between various treatments: SPI versus control; E 2 versus control; and SPICE 2 versus control, criteria: OC1 . 5 or !K1 . 5 (i.e. G 1 . 5), and P!0 . 05. This list of differentially expressed genes was used to evaluate the pattern of gene expression profile by hierarchical clustering, using GeneSpring software or Cluster 2.1.1 and 'Tree View' version 1.60 software supplied by Eisen Lab, Stanford University (http://rana.lbl.gov/EisenSoftware. htm). The top networking pathways, canonical functions, and top molecular functions were determined by Ingenuity Pathway Analysis (IPA) software (Ingenuity Systems, Inc, Redwood City, CA, USA).
Microarray validation by real-time PCR
Total RNA (1 mg) was reverse-transcribed using iSCRIPT cDNA synthesis kit (Bio-Rad) following the manufacturer's instructions. cDNA samples were amplified using previously described conditions (Singhal et al. 2008a) . RT-PCR was performed on nine randomly chosen genes, some of them were of interest and discussed in the results and discussion section. Expression levels of genes were normalized to Gapdh gene levels.
Statistical analysis
Statistical analysis was performed using Sigma Stat software package (Systat Software Inc, San Jose, CA, USA). Data were analyzed by two-way ANOVA followed by Student-Newman post hoc test and were considered significant if P!0 . 05.
Differences between treatment groups in microarray data were analyzed by 'fold changes in volcano plot' (GeneSpring Software) and changes were considered significant at G1 . 5-fold and P!0 . 05 followed by Benjamini and Hochberg multiple testing correction for false discovery rate.
Results
Organ weight and serum E 2 levels E 2 infusion in ovariectomized rats for 14 d resulted in a reduction (P!0 . 05) in body weight (BW) while the relative liver and wet uterus weights (organ weight normalized to the BW) were increased (P!0 . 05), as compared with the non-E 2 infused groups fed with either CAS or SPI diets, nZ6. SPI feeding, in the presence or absence of E 2 infusion, did not have any effect on total BW or relative liver and uterus weights. Serum E 2 levels were higher (P!0 . 05) in the group infused with E 2 compared with non-E 2 groups; no effect of SPI feeding was observed on the serum E 2 levels. Moreover, no interactions, on either parameter mentioned here, were observed between SPI and E 2 , statistically determined by two-way ANOVA (Table 1) .
Serum isoflavones
When fed with SPI the total isoflavone concentrations (aglyconeCconjugates) of genistein, daidzein, equol, and glycetin were 0 . 4G0 . 081, 0 . 26G0 . 053, 0 . 24G0 . 7, 0 . 04G0 . 005 mg/ml respectively. SPI feeding in the presence of E 2 increased (P!0 . 05, nZ6) the levels of equol to 0 . 57G0 . 07 mg/ml while genistein, daidzein, and glycetin were 0 . 26G0 . 063, 0 . 16G0 . 025, and 0 . 02G0 . 002 mg/ml respectively. Two-way ANOVA suggested an interaction between SPI and E 2 resulting in an increase in equol levels. No effect of E 2 on the summed total serum isoflavone levels, 1 . 27G0 . 19 mg/ml by SPI feeding in the absence of E 2 and 1 . 35G0 . 24 mg/ml by SPI feeding in the presence of E 2 , was observed (Table 2) .
Hierarchical clustering
The list of 'differentially expressed genes' contained 1160 genes with known biological functions. Correlation-based unsupervised hierarchical clustering analysis was performed on the treatment (x-axis) and gene expression type (y-axis). The E 2 treated groups -E 2 (CASCE 2 ) and SPICE 2 -clustered together, while the control (CAS) and SPI clustered together, suggesting greater common effects of E 2 treatment on hepatic genes irrespective of the diets. Using pseudogene lines, the heat-map was divided into four sub-clusters: I -genes induced by E 2 ; II -genes induced by SPI; III -genes repressed by E 2 ; and IV -genes repressed by SPI (Fig. 1A) .
Global hepatic gene signature of SPI versus E 2 E 2 treatment resulted in significant modulation (fold changeinduction or repression by more than 1 . 5-fold; and P!0 . 05) of the expression profile of 892 genes; 188 upregulated and 704 downregulated. The top three networks with maximum number of genes affected, as identified by GeneSpring and IPA, were: metabolism and transport; cellular growth and proliferation; and cell cycle. Early genes responsive to stress -leukemia inhibitory factor receptor (Lifr, 43-fold), nephroblastoma overexpressed (Nov, 10 . 6-fold), and early growth response-1 (Egr1, fivefold) genes expression -were highly induced. The E 2 treatment has been associated with altered hepatic glucose homeostasis, improved insulin sensitivity, reduction in obesity, and lipid metabolism (Boverhof et al. 2004 , Gao et al. 2006 . Similar to other investigators, we observed a modulation in genes involved in glucose homeostasis and insulin sensitivity, including an upregulation in insulin-like growth factor-binding protein 1 (Igfbp-1 and -2) and insulin receptor-related receptor (Insrr) by 4-and 1 . 6-fold, while insulin receptor substrate 3 (Irs3) and insulin induced gene 2 (Insig2) were downregulated by 3 . 7-and 1 . 8-fold
respectively. Genes involved in fatty acid metabolism and transport such as carnitine acetyltransferase (Crat), fatty acid desaturase3 (Fad3), fatty acid-binding protein 2 (Fabp2), Cd36, carnitine palmitoyltransferase 1 (Cpt1), and hydroxysteroid 17b dehydrogenase 3 (Hsd7b3), were upregulated. A list of genes altered by E 2 treatment is included in online supplementary material (OSM Table 1 , see Supplementary data in the online version of the Journal of Endocrinology at http://joe. endocrinology-journals.org/content/vol202/issue1/). Functional role of estrogens in protection of premenopausal women against inflammatory and fibrogenic hepatic diseases has been established (Shimizu & Ito 2007) . The mechanisms, however, are not well known. Transforming growth factor-b (Tgfb) plays a crucial role in hepatic fibrogenesis (Parsons et al. 2007) and estrogens have been known to reduce CCl 4 -induced liver fibrosis in rats (Xu et al. 2002) . Here, we found that E 2 supplementation resulted in reduced Tgfb1 gene expression. IPA identified an enrichment in downregulation of genes encoding the entire TGF1 network -TGF-receptor, TGF-inducible homeobox-1, matrix metallopeptidase 2 (Mmp2), tissue inhibitor of metalloproteinase-3 (Timp3), and Smad-2/3 were downregulated (OSM Figure 1A , see Supplementary data in the online version of the Journal of Endocrinology at http://joe. endocrinology-journals.org/content/vol202/issue1/). SPI feeding to the mature female rats in the absence of endogenous estrogens resulted in the modification in the expression profile of 82 genes (Venn diagram Fig. 1B ). Among the 46 upregulated genes, many belong to metabolic processes. For example, glucose metabolism included phosphatidyl inositol 3-kinase (Pi3ka) and early hepatic insulin-responsive gene -Eiih genes; xenobiotic metabolism included glutaredoxin1 (Glrx1) and glutathione-s-transferase (Gst) genes; and fatty acid metabolism including the gene coding for CD36. The downregulated genes included genes coding for estrogen metabolism, sulfotransferase (Estsul/Ste) and transcriptional regulator, Cbp/p300-interacting transactivator (Cited2) and hairy and enhancer of split 1 (Hes1). A complete list of genes altered by SPI treatment is provided in OSM Table 2 , see Supplementary data in the online version of the Journal of Endocrinology at http://joe. endocrinology-journals.org/content/vol202/issue1/. Networking of genes altered by SPI feeding is represented in OSM Figure 1B .
Analysis of genes altered by both SPI and E 2 revealed 39 genes in common (Venn diagram Fig. 1B) . Correlation-based hierarchical cluster analysis (OSM Figure 2 , see Supplementary data in the online version of the Journal of Endocrinology at http://joe.endocrinology-journals.org/ content/vol202/issue1/) of these 39 genes suggested that not all of the genes altered by SPI were in the same direction as E 2 . Expression of four genes downregulated by R1 . 5-fold by E 2 treatment viz. cysteine-and glycine-rich protein 2 (Csrp2), cathepsin C (Ctsc), inositol (myo)-1 monophosphatase 2 (Impa2), and carnitine O-octanoyltransferase (Crot), were upregulated by SPI feeding by R1 . 5-fold, while E 2 upregulated arrestin domain-containing 2 (Arrdc2) gene was downregulated by SPI, suggesting whether SPI has estrogenlike actions or anti-estrogenic actions is dependent upon the individual gene and cannot be generalized. Some genes highly upregulated by E 2 treatment -Lifr (43-fold) and Cd36 (9-fold) -were increased following SPI feeding only by 2 . 5-and 2-fold respectively; while, HLA-B-associated transcript 1A (Bat1) and Cyp2C13, genes highly downregulated by E 2 treatment by 8 . 1-and 5 . 5-fold respectively, were repressed by SPI feeding by only 5 . 3-and 3 . 8-fold respectively (Table 3) .
Genes changed by the interaction between E 2 and SPI Expression profile of 225 genes was modulated (P!0 . 05, 1 . 5-fold) by the interaction between SPI and E 2 , not by either treatment alone (Venn diagram Fig. 1B ). IPA performed (A) Hierarchical cluster analysis of SPI altered (G1 . 5-fold, P!0 . 05) hepatic genes in the presence or absence of E 2 . The heat map was generated from the differentially expressed gene list in GeneSpring software. Using pseudolines, the heat map was divided into four clusters -1) genes induced by E 2 ; 2) genes induced by SPI; 3) genes repressed by E 2 ; and 4) genes repressed by SPI. Colors -orange, yellow, and blue represent upregulation, no relative effect, and downregulation of hepatic genes respectively. (B) Venn diagram on the differentially expressed genes (described in Materials and Methods).
The GCK-regulatory protein, Gckr, was reduced by 1 . 54-fold. Transcription factors -CCAAT/enhancer-binding protein (C/EBPa and -b) -co-regulated by Srebp and GR were downregulated by 1 . 5-fold. Gene coding for farensyl-X-receptor, Fxr, a transcription factor involved in the cholesterol metabolism, and regulated by CEBPa was downregulated by 1 . 6-fold, resulting in the increased expression of the FXR-repressed gene -Cyp7a1, involved in the catabolism of cholesterol to bile acids, by 2 . 8-fold (Fig. 2) .
A more detailed classification of gene expression changes as based on known biological functions, derived from NetAffx and GeneSpring programs, is represented in Table 4 . Corroboration of the microarray results by QRTPCR for a selected group of genes is shown in (Fig. 3) . Statistics performed on nine selected genes expression values from the real-time PCR suggest similar interactions to those observed in our microarray analysis.
Discussion
Several in vivo and in vitro studies suggest that consumption of soy foods, such as soy infant formula, may have adverse effects on development, breast cancer, and reproduction, as the result of estrogenic actions of soy isoflavones (Duffy et al. 2007 , Bhatia & Greer 2008 , Boucher et al. 2008 . These purported estrogenic effects have been attributed to soy isoflavones binding to and activating ERa and/or ERb (Casanova et al. 1999 , Beck et al. 2003 . If consumption of soy foods activates estrogen signaling pathways, one would expect that animals treated with estrogens or fed diets with SPI would have similar gene expression profiles. We used two 'bioassays' of estrogen actions: a) uterine wet weight is a traditional and widely employed bioassay of classical estrogenicity; and b) hepatic genomic profiling in ovariectomized rats fed SPI-or CAScontaining diets, with or without restoration of E 2 to physiologically relevant plasma concentrations. Our results clearly demonstrate that SPI does not elicit responses characteristic of E 2 , the major estrogen in women, in these tissues. On the other hand, and in agreement with findings made by others (Adlercreutz et al. 1993 , Welshons et al. 2006 , we observed that estrogenic status is a key factor in determining the SPI-mediated response.
Our rat studies were designed to closely model soy consumption by pre-and post-menopausal women, conditions of 'normal' and low E 2 levels respectively. Our results clearly demonstrate that irrespective of the estrogenic status, feeding SPI-containing diets to rats does not restore OVXmediated loss in uterine wet weight whereas E 2 supplementation does. Although normally performed in immature rodents, the uterotrophic response is used as a classic bioassay for determining ERa agonists (OECD 2001 , Padilla-Banks et al. 2001 ). Thus, current findings and our previous data demonstrate that SPI feeding does not elicit classical estrogenic responses on ERa-responsive tissues such as the uterus, even when utilized as the sole protein source. By contrast, mature OVX rats fed purified equol (400 mg/kg) or injected with purified genistein (54 mg/kg) displayed mild estrogen-like uterine stimulation (Rachon et al. 2007a , Rimoldi et al. 2007 . Studies utilizing purified soy isoflavones were shown to regulate gene expression similar to estrogens in female (Naciff et al. 2002) and male reproductive tissues (Naciff et al. 2004 (Naciff et al. , 2005 . However, other studies comparing SPI with genistein at the gene expression level in female reproductive tissues revealed a completely different set of genes expressed following SPI feeding compared with feeding purified genistein at the same levels present in SPI (Eason et al. 2005 , Su et al. 2007 . Thus, when the results of these published studies are considered in combination with our results, it is clear that the effects of purified soy isoflavones differ from that of SPI feeding, even when the dose of isoflavones are approximately the same. Analysis of total serum isoflavone concentrations showed that while feeding diets in which SPI represented the sole protein source resulted in substantial concentrations of genistein, daidzein, and equol (levels of genistein equaling those of infants fed soy formula), these concentrations were not sufficient to exhibit classical estrogenic responses mediated through ERa. One interesting finding was that serum equol concentrations in SPI-fed rats treated with E 2 were greater than those of vehicle-treated SPI-fed rats. Equol is the most potent isoflavone metabolite and is produced in all or most rodents and monkeys, but in only about 25% of human subjects, and is not produced in human infants (Gu et al. 2006) . We have no explanation of the elevated serum equol concentrations, but since equol is formed in the gut by bacterial metabolism of daidzein, E 2 may promote daidzein metabolism. This may have functional significance for women who are equol producers and who also take birth control pills or estrogen replacement therapy.
Our current weight gain data support those of others showing an attenuation of BW following E 2 supplementation in OVX rats (Cooke & Naaz 2004 , Rachon et al. 2007a . However, no such effects were observed with SPI feeding. Additionally, SPI feeding did not alter serum E 2 levels. Treatment with purified genistein, however, reduces the activity of aromatase, the enzyme that metabolizes androgen to estrogens, resulting in reduced serum E 2 concentrations (Adlercreutz et al. 1993) . This is another example of differing actions of SPI and purified isoflavones.
It has been noted that making conclusions based on the estrogen-dependent changes in the whole genomic profile is more sensitive than relying on single bioassays such as uterine hyperplasia (Naciff et al. 2004) . Previously, it was demonstrated that the gene expression profile in uterus and ovary of immature Sprague-Dawley rats fed with Purina 5001 diet (total genisteinCdaidzeinZ0 . 49 mg/g was completely different from low doses of ethinyl E 2 (0 . 1 mg/kg per day for 4 d). Additionally, similar to our current data, no uterine stimulation was observed, suggesting no estrogenic effect of laboratory animal feed on the reproductive system in the immature female rat (Naciff et al. 2004) . In the present study, liver was selected to compare the gene expression profile of SPI with E 2 . Although not involved in reproduction, liver is a highly estrogen-responsive tissue as evident from the role of estrogens in the regulation of liver regeneration, inflammation and injury, and hepatic insulin sensitivity, as well as lipid-and sterol-mediated signaling (Hall et al. 2001 , Murphy & Korach 2006 . The liver also predominately expresses ERa (Kuiper et al. 1997) , although low levels of ERb have been reported (Petersen et al. 1998 ) and serves as a relatively clean tissue to study the effect of exogenous and endogenous estrogens on classical ERa signaling. We have identified a significant alteration in the gene expression profile of 892 genes, which itself suggests that estrogens are robustly involved in hepatic signaling. Genes involved in physiological processes including lipid and cholesterol metabolism, fibrogenesis, xenobiotic metabolism, transport, inflammation, cellular proliferation, and differentiation were altered by E 2 supplementation, as previously reported by other laboratories (Gao et al. 2006 (Gao et al. , 2008 .
The relevance of the current study is in the comparison of gene expression signatures of SPI fed with E 2 -treated ovariectomized rats. SPI feeding resulted in significant alterations in the expression of only 82 genes. IPA identified SPI-altered genes that are also regulated by estrogens and progesterone, such as aquaporin1 (Aqp1), Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 (Cited2), and phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 1 (Pik3r1), revealing that some E 2 -regulated genes are also regulated by SPI (OSM Table 2 ). Naciff et al. (2004) reported a downregulation of Aqp1, a gene encoding a protein that is a member of a family of membrane channel proteins which facilitate bulk water transport and aquaporins, by soy/alfalfa-based diet in immature rat uterus, which was opposite to the effect of estrogenic stimulation by a high E 2 dose (Li et al. 1997) . Interestingly, we also found a suppression of this gene by SPI feeding; however, no estrogenic stimulation was observed. Further comparative analysis determined that genes common to SPI feeding and E 2 treatment, 39 genes, were only 4% of the genes changed by E 2 , suggesting an involvement of different biologic pathways in SPI-mediated signaling. Among these 39 genes, very few were identified by PROMOSER (Halees et al. 2003) , a large-scale mammalian promoter and transcription start site identification service available online. The promoter analysis performed on the selected genes identified by PROMOSER revealed that only a few of these genes possessed estrogen-responsive element (ERE), binding sites for ER, as identified by DRAGON ERE version 2.0 program (Bajic et al. 2003) . Immediate early genes -Lifr (E 2 : 43-fold; and SPI: 2 . 5-fold induction) and Egr1 (E 2 : fivefold; and SPI: no induction) -were identified with ERE-like consensus sequences (GGTCAnnnTGACC) and half EREs (GGTCA) in the promoter element upstream -5000 of transcription start site, suggesting a direct E 2 -mediated transcriptional increase in these genes, while Cd36 gene (E 2 : ninefold; and SPI: twofold induction) lacked any ERE-like sequence. This suggests that E 2 -or SPI-mediated hepatic signaling does not necessarily involve classical ER/ERE pathways. Genome-wide identification of ERa-binding sites in mouse liver, using ChIP on Chip molecular technique, suggested that besides ERE a number of motifs including forkhead sites, AP-1, Sp1, bHLH, and ETS sites are important for E 2 -mediated hepatic gene expression (Gao et al. 2008) . Our data suggest that SPI-feeding results in a unique signature in hepatic gene expression. Phytoestrogens present in SPI may change expression of a few genes by ERa recruitment to EREs or by modulating other transcription factors that mediate estrogenic responses. Hierarchical clustering revealed that SPI feeding altered the expression of five genes in the direction opposite to E 2 treatment, demonstrating a SERM-like action of SPI on selective genes. Whether the effect of SPI would be the same or opposite to E 2 depends solely upon the gene type and cannot be generalized. Interestingly, 225 genes were uniquely modulated by the combination of E 2 plus SPI and not by either treatment alone. The biochemical and physiological effects of SPI are known to be affected by the estrogenic status (Adlercreutz et al. 1993 , Welshons et al. 2006 . For example, both SPI and E 2 enhanced DMBA-mediated Cyp1a1 induction in ovariectomized females but this was repressed by SPI feeding in the presence of E 2 (Singhal et al. 2008b) . Interaction between SPI-associated phytochemicals and peptides, and E 2 may alter the expression profile and binding pattern of transcription factors, co-activators, and co-repressors resulting in the modulation of gene expression. Here, we observed changes in the expression profile of many transcription factors, including RNA polymerase II (Pol II ), responsible for transcriptional elongation of genes. Repression in the expression of Pol II was linked with reduced expression of many transcription factors such as Cebp-a and -b, Dbp, glucocorticoid receptor, Fxr, and Srebp1, suggesting altered metabolic profile by the combination of SPICE 2 , as compared with SPI or E 2 alone. This also strengthens the point that the SPI gene expression signature in: children prior to puberty, men and women, and post-menopausal women would all be predicted to differ.
Conclusion
The present data demonstrate that SPI, the sole protein source of infant formula, is not uterotrophic and it has a unique pattern of hepatic gene expression that differs substantially from that of E 2 . These data call into question concerns about the potential estrogenic effects of soy formulas in infants (5, 6, 12-15, 59, 60) . It should be noted that the rats with access to SPI ad libitum consumed 19 . 3 mg/kg per day of genistein , which is much higher than the average intake of genistein in US (0 . 014-0 . 14 mg/kg per day) or in Japan (0 . 21-0 . 43 mg/kg per day; Rozman et al. 2006) or infants on soy formula 4-6 mg/kg per day (Setchell et al. 1997) . It is unlikely that the general population would consume sufficient amounts of phytoestrogens in the diet to cause any adverse effects. Our conclusion in liver is also supported by a series of studies performed by Naciff et al. in reproductive tissues in immature rats where soy-containing diets were not observed to be estrogenic. However, further validation of the current data by examining the SPI gene signature in estrogen-responsive reproductive tissues containing both ERa and ERb in neonatal animals such as a piglet, which have a more similar pattern of isoflavone metabolites to humans than rodents (Gu et al. 2006 ) is required to completely rule out the possibility of estrogenic effects of soy infant formula. 
Declaration of interest
Funding
The work presented here is supported in part by USDA (CRIS# 6251-51000-005-03S), a CAGSRF award from UAMS (R S) and a Technology Transfer Award from SCC-SOT (R S).
